CRS Clinical Research Services Management GmbH — Clinical Trial Site

52 Registered trials

2 Currently recruiting

Organisation

CRS Clinical Research Services Management GmbH

Location

Mannheim, Germany

Identifier

ORG-100039537

Address

Siemensdamm 65, Siemensstadt, 13627, Germany

Departments

Abteilung Klinische Studien Phase I/II
Clinic
Clinical Investigator
Clinical Pharmacology Unit
Clinical Pharmacology Unit, Board of Managing Directors
Clinical Unit
CRS Clinical Research Services Berlin GmbH
CRS Clinical Research Services Management GmbH
CRS Clinical Research Services Mannheim GmbH
Dermatology
Mannheim
Mannheim GmbH
Medical & Managing Director
Medical Director
N/A
NA
Not applicable
Phase I Unit

Clinical trials at this site (52)

Search interface

A study in healthy people or otherwise healthy but overweight or obese to compare 2 formulations of survodutide given in different ways, eit… Pending

2025-524135-39-00 Healthy volunteer trial 3
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the E… Recruiting

2023-507039-39-00 Moderate to Severe Plaque Psoriasis 5 2024-03-22
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes ( ENLIGHTEN-1). Recruiting

2025-523657-34-00 Obesity 5 2026-04-13
A Study Evaluating BFB759 in Atopic Dermatitis Ended

2025-521624-30-00 Atopic dermatitis 4 2026-01-08
A study in healthy people to compare how 2 different formulations of survodutide are taken up by the body Ended

2025-522325-35-00 Healthy volunteer trial 3 2025-10-27
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Atopic Dermatitis Ended

2024-515494-95-00 Moderate to Severe Atopic Dermatitis (AD) 4 2025-05-26
A Phase 3 Placebo-Controlled Study With Randomized Dose Up/Dose Down Extension Period Investigating the Efficacy, Safety, and Tolerability o… Ended

2022-502518-98-00 nonsegmental vitiligo 5 2024-04-26
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatm… Ended

2023-505122-34-00 Plaque Psoriasis 5 2023-12-05
A study in healthy men to test whether carbamazepine influences the amount of nerandomilast in the blood Ended

2025-521279-30-00 Healthy volunteer trial 3 2025-08-06
A study in healthy people to compare how 2 different formulations of survodutide are taken up in the body Ended

2025-521419-37-00 Healthy volunteer trial 3 2025-07-22
A study in healthy people to test whether erythromycin influences the amount of BI 1291583 in the blood. Ended

2024-515795-12-00 Healthy volunteer trial 3 2025-04-29
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults with Type 2 Diabetes M… Ended

2024-512562-34-00 Type 2 Diabetes Mellitus 4 2025-02-24
Phase 1 first-in-human, single and multiple dosing study of FB301 in healthy female subjects Ended

2024-517539-38-00 Women infertility 1 2025-02-13
Effects of AZD5004 in adults who are living with obesity or overweight with at least 1 weight-related medical condition Ended

2024-513691-18-00 Participants living with Obesity or Overweight with at 4 2024-12-11
A clinical trial to determine if AIC263029 is safe when dosed only once or several times, and to investigate how it moves within the human b… Ended

2023-510074-13-00 BKV-associated nephropathy 1 2024-10-02
A Study to Evaluate the Effects of Various Degrees of Hepatic Impairment on the Pharmacokinetics of A Single Subcutaneous Dose Of RO7434656,… Ended

2023-508270-29-01 Hepatic Impairment 3 2024-09-24
A Phase I study to evaluate the pharmacokinetics, safety and tolerability of multiple oral doses of obefazimod in participants with renal im… Ended

2024-514561-20-00 Moderately to severely active ulcerative colitis 3 2024-09-09
Effect of Renal Impairment on Enpatoran Pharmacokinetics Ended

2024-513393-22-00 Healthy volunteers and patients with renal impairment; 3 2024-09-04
A study to learn about the safety of BAY 3283142 in people with mild to moderate high blood pressure Ended

2024-512060-58-00 Chronic kidney disease 3 2024-08-07
A randomized, single-center, double-blind, placebo-controlled, first-in-human trial with single and multiple ascending doses to determine sa… Ended

2024-512510-17-00 Treatment of pain 1 2024-08-05
A study to learn about the amount of asundexian in the blood when healthy participants take different types of asundexian tablets Ended

2023-509447-28-00 Prevention of ischemic stroke in patients post acute no 3 2024-07-26
A Phase 1, Open-Label, Non-Randomized, Single-Center, Single-Dose Study to Assess the Pharmacokinetics and Safety of ANT3310 Combined with M… Ended

2024-512617-41-00 Renal impairment 3 2024-07-19
A study to learn about the taste of Vericiguat given in liquid form in healthy male participants aged 18 to 45 years Ended

2023-508447-52-00 Heart failure in children 3 2024-06-28
An Open-label, Single-dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-77242113 in Adult Participants Ended

2023-510161-97-00 Renal Impairment 3 2024-06-19